NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/18/2025
Back to search
Official data from USPTO
DENK INGREDIENTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DENK INGREDIENTS
ST13
US500000079271037Class
1, 3, 5, 35
Filing
79271037
Registration
6177146
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
11/19/2025
Trademark type
Word
Nice classes
1, 3, 5, 35
Filing date
05/16/2019
Registration date
10/20/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/20/2020
Last transaction
11/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
SABLE, ERIC
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DENK PHARMA GmbH & Co. KG
Denk Ingredients GmbH
Representatives
Keith A. Weltsch Scully, Scott, Murphy & Presser, P.C.
Technical classification
Nice Classes
Class 1Class 3Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industryscienceagriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticidesin particular for use in the fooddietary supplementpharmaceutical and cosmetics industriesincluding in the form of precursors and intermediatesbeing additives and auxiliaries; artificial sweeteners
Class 3
Plant extracts and vegetable oils for cosmetic purposesincluding in the form of precursors and intermediatesbeing additives and auxiliariesplant extracts and vegetable oils sold as components of cosmetics
Class 5
chemicals for pharmaceutical and medical purposes sold as the components of pharmaceutical preparations for the treatment of diseases and/or conditions of alimentary tract and metabolismblood and blood forming organscardiovascular systemgenito-urinary system and sex hormonesantiinfectives for systemic usemusculo-skeletal systemnervous system and respiratory systemdisturbances with and support of digestive enzymesfor optimizing the supply of nutrients to mother and childfor the promotion of fertilityfor the relief and elimination of lactose intolerancefor the development of teethbones and muscles growthfor care during pregnancy and breastfeedingfor supporting the memoryconcentration and learningfor the care of the immune systemfor the strengthening and maintenance of jointscartilagebones and musclesfor the magnesium supply of heartnerves and musclesfor increasing the iron requirementfor increasing the sperm formation and for the folic acid care before and during pregnancy; animal and vegetable oils and plant extracts for pharmaceutical and medical purposes sold as components of pharmaceutical preparations for the treatment of diseases and/or conditions of alimentary tract and metabolismblood and blood forming organscardiovascular systemgenito-urinary system and sex hormonesantiinfectives for systemic usemusculo-skeletal systemnervous system and respiratory systemdisturbances with and support of digestive enzymesfor optimizing the supply of nutrients to mother and childfor the promotion of fertilityfor the relief and elimination of lactose intolerancefor the development of teethbones and muscles growthfor care during pregnancy and breastfeedingfor supporting the memoryconcentration and learningfor the care of the immune systemfor the strengthening and maintenance of jointscartilagebones and musclesfor the magnesium supply of heartnerves and musclesfor increasing the iron requirementfor increasing the sperm formation and for the folic acid care before and during pregnancy; protein supplements for pharmaceutical and medical purposes; nutritional supplements for pharmaceutical and medical purposes; all the aforesaid goods being in the form of precursors and intermediatesbeing additives and auxiliaries
Class 35
Wholesale and retail store services featuring pharmaceutical and chemical preparations used in industryscienceagriculturehorticulture and forestryespecially for use in the foodstufffood supplementpharmaceutical and cosmetics industriesartificial sweetenerspains and dietsplant extracts and plant oils for cosmetic purposeschemical preparations for pharmaceutical and medical purposesanimal oils and plant oils as well as plant extracts for pharmaceutical and medical purposesproteins for pharmaceutical and medical purposesfood supplements for pharmaceutical and medical purposesminerals and vitamins
Publications
History of USPTO decisions and trademark events.
32 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/20/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/10/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/07/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/06/2021
FIMP
FINAL DISPOSITION PROCESSED
02/06/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/20/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/20/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/04/2020
PUBO
PUBLISHED FOR OPPOSITION
08/04/2020
GPNX
NOTIFICATION PROCESSED BY IB
07/31/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/15/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/15/2020
ALIE
ASSIGNED TO LIE
06/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/29/2020
DCPN
CHANGE OF OWNER RECEIVED FROM IB
06/25/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/15/2020
ATRV
ATTORNEY REVIEW COMPLETED
01/13/2020
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
01/10/2020
RFNT
REFUSAL PROCESSED BY IB
01/04/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
12/27/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/13/2019
RFRR
REFUSAL PROCESSED BY MPU
12/13/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/20/2019
CNRT
NON-FINAL ACTION WRITTEN
11/19/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/16/2019
DOCK
ASSIGNED TO EXAMINER
11/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/12/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/02/2019
Continuous trademark protection
Get notified about every new filing that threatens DENK INGREDIENTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.